Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06980428) titled 'A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels' on May 19.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).
Primary Sponsor: AstraZeneca
Condition:
Healthy Participants
Intervention:
Drug: AZD4954
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: May 26, 2025
Target Sample Size: 120
Countries of Recrui...